Company Filing History:
Years Active: 2015
Title: Inventor Carsten Overblle Petersen: Innovating Pharmaceutical Purification
Introduction
Carsten Overblle Petersen, a notable inventor based in Hvidovre, Denmark, has contributed significantly to the field of pharmaceuticals. His work centers around enhancing the purification processes of critical therapeutic substances, demonstrating his commitment to innovation and healthcare improvement.
Latest Patents
Petersen holds a patent for a groundbreaking method titled "Method for purification of colistin and purified colistin components." This invention outlines a process that involves the use of reverse phase chromatography for purifying colistin. The method entails loading a column with colistin base utilizing acetic acid and a high ethanol concentration, followed by eluting with a low ethanol concentration. This innovative approach promises improved efficiency and effectiveness in the purification of colistin, a vital antibiotic used in treating serious bacterial infections.
Career Highlights
Carsten Overblle Petersen is currently associated with Xellia Pharmaceuticals Aps, a leading company specializing in developing and manufacturing critical antibiotics. His role within the organization has allowed him to focus on his research and innovate within the pharmaceutical industry, particularly regarding antibiotic purification technologies.
Collaborations
Petersen collaborates closely with Torben Koch, a fellow researcher and coworker at Xellia Pharmaceuticals. Their partnership exemplifies the power of teamwork in fostering advancements in pharmaceutical science, as they work together to push the boundaries of existing technologies and methods.
Conclusion
In summary, Carsten Overblle Petersen stands out as a dedicated inventor whose contributions to the pharmaceutical field, particularly through his patent on colistin purification, are helping pave the way for better therapeutic solutions. His collaborative efforts with peers like Torben Koch further enhance his impact, driving innovation forward in the realm of antibiotic development and purification technologies.